Gambro Lundia Ab

Karin Sandin

Ola Carlsson

Anders Wieslander

Simon Enarsson

Anna Bryland

Olof Jansson

Sture Hobro

Viktoria Hancock

Anna Szilagyi

Torbjörn Linden

Husam Mohammed

The invention provides a first concentrate comprising lactate and calcium ions, said first concentrate having increased stability against precipitation at temperatures around +4° C., said first concentrate being useful for preparing a ready-to-use dialysis fluid by mixing said first concentrate with water and optionally a second concentrate comprising glucose, wherein that the lactate concentration L(expressed in moles per litre, M) of the concentrate fulfills the conditions: a) L>0.8 M; and b) L<(1.9−0.4×Ca) M; and wherein Cais the calcium concentration of the ready-to-use dialysis fluid expressed in millimoles per litre (mM).

Dialysis concentrate

The present invention concerns a system for preparing a ready-to-use peritoneal dialysis fluid. The system comprises a) a proportioning device; b) at least one source of water; c) at least one source of first concentrate adapted for connection with a) and b), d) at least one source of second concentrate adapted for connection with a) and b), and optionally, e) at least one source of further concentrate adapted for connection with a) and b), wherein the first concentrate comprises glucose and has a pH of between 1.5 and 4, and wherein the second concentrate comprises a physiologically acceptable buffer and has a pH of between 5.5 and 9.0.

System for proportioning fluids

A replacement fluid for dialysis treatment includes selenium in a concentration of 0.6-1.8 &#x3bc;M, and rubidium in a concentration of 1.4-4.2 &#x3bc;M. The replacement fluid is essentially free of one or more of the trace elements selected from chromium, manganese, and copper.

Dialysis formulation

The invention relates to a dialysis formulation, optionally a citrate containing dialysis formulation, comprising selenium (Se), optionally in combination with further trace elements selected from rubidium (Rb), cobalt (Co), molybdenum (Mo), and zinc (Zn). The dialysis formulation is intended to be used in dialysis treatment.

Growing community of inventors

Sodra Sandby, Sweden

Karin Sandin